Literature DB >> 1979001

Effects of dopamine D-1 and D-2 antagonists on decision making by rats: no reversal of neuroleptic-induced attenuation by scopolamine.

T Ljungberg1, M Enquist.   

Abstract

The effects of the dopamine (DA) D-1 antagonist SCH 23390 and the D-2 antagonists haloperidol and sulpiride on decision making in thirsty rats were investigated. The problem given to the rats was to choose between two behaviours, locomoting or lever-pressing, in order to obtain rewards (water). SCH23390 and haloperidol dose-dependently reduced the number of rewards obtained. However, only minor effects were seen on the decision making parameters. DA is thus important for initiation and/or performance of learned behavioural acts, not for information sampling and processing leading to the decision of which behaviour to perform. There were no differences between D-1 and D-2 antagonism in this respect. After sulpiride, no significant effects were observed. A specific behavioural prolife obtained by extinction was not mimicked by any of the doses of neuroleptics tested. It has previously been shown that performance per se of the two behavioural options used in the task can be reinstated by scopolamine after haloperidol attenuation. However, when these options had to be organized into functional sequences to reach a goal, haloperidol-induced attenuation could not be counteracted by scopolamine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979001     DOI: 10.1007/bf01272760

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  28 in total

1.  An analysis of behavioural effects produced by drug-induced changes of dopaminergic neurotransmission in the brain.

Authors:  S Ahlenius
Journal:  Scand J Psychol       Date:  1979

2.  Effects of the dopamine D-1 antagonist SCH 23390 on water intake, water-rewarded operant responding and apomorphine-induced decrease of water intake in rats.

Authors:  T Ljungberg
Journal:  Pharmacol Biochem Behav       Date:  1989-07       Impact factor: 3.533

3.  Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

Review 4.  Brain dopamine receptors.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1980-09       Impact factor: 25.468

5.  A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Pharmacol Biochem Behav       Date:  1985-09       Impact factor: 3.533

6.  Scopolamine reverses haloperidol-attenuated lever-pressing for water but not haloperidol-attenuated water intake in the rat.

Authors:  T Ljungberg
Journal:  Pharmacol Biochem Behav       Date:  1988-01       Impact factor: 3.533

7.  Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behaviour and catalepsy in rats: behavioural profile comparisons between raclopride, haloperidol and preclamol.

Authors:  V Hillegaart; S Ahlenius
Journal:  Pharmacol Toxicol       Date:  1987-05

8.  Reversal of haloperidol induced deficits in self-stimulation by anti-Parkinsonian drugs.

Authors:  R J Carey
Journal:  Behav Brain Res       Date:  1983-12       Impact factor: 3.332

Review 9.  The role of dopamine in locomotor activity and learning.

Authors:  R J Beninger
Journal:  Brain Res       Date:  1983-10       Impact factor: 3.252

10.  Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission.

Authors:  S Ahlenius; V Hillegaart
Journal:  Pharmacol Biochem Behav       Date:  1986-05       Impact factor: 3.533

View more
  2 in total

1.  Chronic Exposure to Methamphetamine Disrupts Reinforcement-Based Decision Making in Rats.

Authors:  Stephanie M Groman; Katherine M Rich; Nathaniel J Smith; Daeyeol Lee; Jane R Taylor
Journal:  Neuropsychopharmacology       Date:  2017-07-25       Impact factor: 7.853

2.  Microcatalepsy and disruption of forelimb usage during operant behavior: differences between dopamine D1 (SCH-23390) and D2 (raclopride) antagonists.

Authors:  S C Fowler; J R Liou
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.